Explore daily insights on
Celestica falls 14% on earnings beat and raise amid execution concerns
Celestica (CLS.TO) shed roughly C$10 billion in market value on April 29 despite reporting Q1 2026 results with 53% year-on-year revenue growth and raised full-year 2026 revenue guidance to $19.0 billion from $17.0 billion, while guiding to adjusted EPS of $10.15. The updated outlook implies roughly a 28% half-over-half revenue ramp in the second half of 2026, raising investor concerns about execution risk. The stock climbed about 50% in the past month and is up roughly 380% over the past year, which left little room for anything short of spectacular results.
Supporting datasets
Supporting queries
To surface this insight, Baselight ran 10 queries across its structured data. Each one is reproducible — open it, read the SQL, and rerun it yourself.
Conclusion
CLS.TO closed C$515.17 on Apr 29 vs Apr 27 close of C$576.75 (−14.2%); 52-week high C$576.89; volume 547,756 vs 20-day avg 727,738. Q1 revenue $4.05B (+53% YoY); adjusted EPS $2.16 (beat high end of guidance). FY 2026 revenue guidance raised to $19.0B from $17.0B; adjusted EPS raised to $10.15 from $8.75. The $2B revenue raise implies ~28% H2 ramp. Stock up 50% in April and 380% over past 12 months prior to earnings. News: 'Celestica craters by $10B after earnings' (TheStreet, Apr 29); 'Celestica's selloff reflects sky-high expectations and concerns about a steep second-half ramp' (TheStreet, Apr 29).